SANTA CLARA, Calif. & GUANGZHOU, China–(BUSINESS WIRE)–Agilent Technologies Inc. (NYSE:A) and Burning Rock today announced they have signed an agreement under which Burning Rock will develop cancer diagnostics in China based on the Agilent SureSelect target enrichment system. Agilent is the leading provider of target enrichment for next-generation DNA sequencing. Target enrichment saves researchers time and resources by enabling them to focus on regions of interest rather than looking at the